Title : VACtívate LATAM: An intervention to promote confidence in maternal vaccination in Latin America
Abstract:
Background: Maternal immunization protects both the pregnant woman and the newborn; however, its benefit depends not only on vaccine availability but also on the confidence underpinning the vaccination decisions of pregnant women and the healthcare staff who care for them. VACtívate LATAM builds on our previous mixed-methods research in Colombia (3,511 participants) and extends it to six Latin American countries: Colombia, Guatemala, Ecuador, Panama, the Dominican Republic and Costa Rica.
Previous findings from Colombia: Among 1,570 pregnant women from eight municipalities with contrasting maternal vaccination coverage, only 18.4% showed a high level of vaccine knowledge, 27.1% a low level, and 35.3% reported low perceived knowledge. Attitudes were favourable in 58.8%, whereas 38.9% remained undecided and 2.4% were unfavourable; 77.4% reported a high level of vaccination practices. Low perceived knowledge was more frequent among women with primary education or less (50.8% vs 17.0% among those with higher education; Cramér’s V = 0.155) and among those attending public rather than private services (36.1% vs 12.7%; V = 0.142). Women in the first trimester showed fewer high-level practices than those in the third (59.6% vs 82.1%; V = 0.134). Attitudes were not correlated with knowledge or practices, suggesting that information alone does not translate into confidence. The GestVac attitude subscales showed adequate internal consistency in pregnant women (α = 0.847; ω = 0.833; CFI = 0.994) and healthcare professionals (α = 0.947; ω = 0.909). In parallel, the VACtívate psychoeducational course, delivered to 716 participants in 20 Colombian cities, significantly increased knowledge scores (W = 14,856.5; p = 0.0007).
Methods: VACtívate LATAM is a mixed-methods study among pregnant women and healthcare staff. The quantitative component involves the cultural adaptation of the GestVac questionnaire (review by the Colombian team and country experts, and cognitive pilot interviews) and its administration to approximately 260 pregnant women per capital city, from the second trimester onwards, and to healthcare staff with at least six months’ experience in prenatal care. The qualitative component comprises focus groups (about 48 participants per country) exploring knowledge, attitudes, practices and experiences related to maternal vaccination.
Intervention: Based on the diagnostic phase, VACtívate LATAM delivers a 12-hour, in-person, certified course to around 50 participants per country, including healthcare staff, community leaders, health authorities and communicators. Its four modules address vaccine education, tools for informed decision-making, leadership in vaccination and the co-creation of public health proposals. The course is evaluated through pre- and post-intervention questionnaires and open-ended questions.
Conclusions: The Colombian evidence shows that maternal vaccine confidence is shaped by knowledge gaps, perceived knowledge and social inequalities in access to care, and not by information alone. VACtívate LATAM translates this evidence into a regional, context-sensitive strategy to strengthen confidence in maternal vaccination across Latin America.

